These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 10767366

  • 1. Intermittent adjuvant chemo-immunotherapy after resection of non-small cell lung cancer with multilevel mediastinal lymph node metastasis.
    Suzuki M, Kimura H, Iwai N, Fujisawa T.
    Oncol Rep; 2000; 7(3):545-9. PubMed ID: 10767366
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
    Kimura H, Yamaguchi Y.
    Lung Cancer; 1995 Aug; 13(1):31-44. PubMed ID: 8528638
    [Abstract] [Full Text] [Related]

  • 3. [Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
    Arnau Obrer A, Martín Díaz E, Pérez Alonso D, Regueiro Mira F, Cervera Juan A, Granell Gil M, Roch Pendería S, Cantó Armengod A.
    Arch Bronconeumol; 2001 Mar; 37(3):121-6. PubMed ID: 11333537
    [Abstract] [Full Text] [Related]

  • 4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer.
    Kimura H, Yamaguchi Y.
    Lung Cancer; 1996 Jun 01; 14(2-3):301-14. PubMed ID: 8794412
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304).
    Tada H, Tsuchiya R, Ichinose Y, Koike T, Nishizawa N, Nagai K, Kato H.
    Lung Cancer; 2004 Feb 01; 43(2):167-73. PubMed ID: 14739037
    [Abstract] [Full Text] [Related]

  • 7. Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.
    Kimura H, Iizasa T, Ishikawa A, Shingyouji M, Yoshino M, Kimura M, Inada Y, Matsubayashi K.
    Anticancer Res; 2008 Feb 01; 28(2B):1229-38. PubMed ID: 18505060
    [Abstract] [Full Text] [Related]

  • 8. Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations.
    Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H.
    Chest; 2000 Jul 01; 118(1):123-8. PubMed ID: 10893369
    [Abstract] [Full Text] [Related]

  • 9. [Surgery and combined therapy for non-small cell lung cancer with invasion of the mediastinal nodes. A retrospective study].
    Arnau Obrer A, Martín Díaz E, Pérez Alonso D, Regueiro Mira F, Cañizares Carretero M, Cervera Juan A, Granell Gil M, Roch Tejerina S, Cantó Armengod A.
    Arch Bronconeumol; 2001 Apr 01; 37(4):160-5. PubMed ID: 11412499
    [Abstract] [Full Text] [Related]

  • 10. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H, Kitagawa C, Ichinose Y, Takenoyama M, Ibata H, Kato T, Takami K, Yamashita M, Maeda T, Takeo S, Ueda H, Okabayashi K, Nagashima S, Oka T, Kouso H, Fukuyama S, Yoshimoto K, Shimokawa M, Saito AM, Ito S.
    Trials; 2017 Sep 15; 18(1):429. PubMed ID: 28915900
    [Abstract] [Full Text] [Related]

  • 11. [The role of adjuvant therapy in the management of pN2 non-small-cell carcinoma of the lung].
    Chella A, Lucchi M, Gragnani F, Ribechini A, Silvano G, Janni A, Mussi A, Angeletti CA.
    Minerva Chir; 1995 Dec 15; 50(12):1029-38. PubMed ID: 8725059
    [Abstract] [Full Text] [Related]

  • 12. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
    Wada H, Miyahara R, Tanaka F, Hitomi S.
    Eur J Cardiothorac Surg; 1999 Apr 15; 15(4):438-43. PubMed ID: 10371118
    [Abstract] [Full Text] [Related]

  • 13. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
    Han H, Zhao Y, Gao Z, Zheng D, Fu F, Zhao Z, Tang Y, Xiang J, Sun Y, Hu H, Chen H.
    J Cancer Res Clin Oncol; 2019 Aug 15; 145(8):2115-2122. PubMed ID: 31175463
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 15; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 15. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
    Scagliotti GV, Fossati R, Torri V, Crinò L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M, Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators.
    J Natl Cancer Inst; 2003 Oct 01; 95(19):1453-61. PubMed ID: 14519751
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Postoperative adjuvant therapy for stage II non-small-cell lung cancer.
    Park JH, Shim YM, Baek HJ, Kim MS, Choe DH, Cho KJ, Lee CT, Zo JI.
    Ann Thorac Surg; 1999 Nov 01; 68(5):1821-6. PubMed ID: 10585065
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.